SCS Capital Management LLC Makes New Investment in Ventas, Inc. $VTR

SCS Capital Management LLC acquired a new stake in Ventas, Inc. (NYSE:VTR) in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm acquired 298,587 shares of the real estate investment trust’s stock, valued at approximately $26,648,000.

Several other hedge funds have also recently modified their holdings of the company. Angeles Wealth Management LLC grew its holdings in shares of Ventas by 4.0% in the first quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock valued at $274,000 after acquiring an additional 128 shares in the last quarter. IHT Wealth Management LLC increased its position in shares of Ventas by 3.2% during the fourth quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after acquiring an additional 137 shares during the last quarter. Sequoia Financial Advisors LLC lifted its holdings in Ventas by 1.2% during the first quarter. Sequoia Financial Advisors LLC now owns 12,894 shares of the real estate investment trust’s stock worth $1,054,000 after acquiring an additional 148 shares during the period. Parallel Advisors LLC lifted its holdings in Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after acquiring an additional 175 shares during the period. Finally, Manchester Capital Management LLC boosted its position in Ventas by 60.5% in the fourth quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock worth $38,000 after purchasing an additional 185 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on VTR. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, July 21st. Cantor Fitzgerald lifted their target price on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Royal Bank Of Canada boosted their price target on shares of Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a report on Friday. JPMorgan Chase & Co. increased their price target on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Monday, May 11th. Finally, Evercore reaffirmed an “outperform” rating and issued a $95.00 price objective on shares of Ventas in a research report on Wednesday, April 29th. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $98.00.

Ventas Stock Up 1.3%

Shares of NYSE VTR opened at $91.48 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The stock has a market capitalization of $46.92 billion, a PE ratio of 169.40, a P/E/G ratio of 2.11 and a beta of 0.69. Ventas, Inc. has a one year low of $66.38 and a one year high of $101.60. The business’s fifty day moving average price is $90.45 and its 200-day moving average price is $86.54.

Insider Transactions at Ventas

In other news, Director Michael J. Embler acquired 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.53% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.